个性化文献订阅>期刊> EMBO journal
 

microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C

  作者 Penna, E; Orso, F; Cimino, D; Tenaglia, E; Lembo, A; Quaglino, E; Poliseno, L; Haimovic, A; Osella-Abate, S; De Pitta, C; Pinatel, E; Stadler, MB; Provero, P; Bernengo, MG; Osman, I; Taverna, D  
  选自 期刊  EMBO journal;  卷期  2011年30-10;  页码  1990-2007  
  关联知识点  
 

[摘要]Malignant melanoma is fatal in its metastatic stage. It is therefore essential to unravel the molecular mechanisms that govern disease progression to metastasis. MicroRNAs (miRs) are endogenous non-coding RNAs involved in tumourigenesis. Using a melanoma progression model, we identified a novel pathway controlled by miR-214 that co-ordinates metastatic capability. Pathway components include TFAP2C, homologue of a well-established melanoma tumour suppressor, the adhesion receptor ITGA3 and multiple surface molecules. Modulation of miR-214 influences in vitro tumour cell movement and survival to anoikis as well as extravasation from blood vessels and lung metastasis formation in vivo. Considering that miR-214 is known to be highly expressed in human melanomas, our data suggest a critical role for this miRNA in disease progression and the establishment of distant metastases. The EMBO Journal (2011) 30, 1990-2007. doi: 10.1038/emboj.2011.102; Published online 5 April 2011

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内